Public list: BIO 2016 (619) Pharma Startups (6570)
ContraFect is a biotechnology company committed to developing technologies, treatments, and products that will target and kill the most virulent and resistant microorganisms-including gram-positive bacteria, such as Staphylococcus (MRSA), and viruses...Show all
Company (IPO / Went public)
Phone: 212-359-9553
28 Wells Avenue
Yonkers, 10701
New York, United States
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Broth microdilution method for evaluating and determining minimal inhibitory concentration of antibacterial polypeptides | May 12, 2017 | Dec 01, 2020 | Patent |
Bacteriophage lysin and antibiotic combinations against gram positive bacteria | May 09, 2013 | Oct 27, 2020 | Patent |
Lysin polypeptides active against gram-negative bacteria | Sep 16, 2016 | Aug 18, 2020 | Patent |
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof | Feb 04, 2015 | May 05, 2020 | Patent |
Bacteriophage lysin and antibiotic combinations against gram positive bacteria | Jun 04, 2013 | Feb 13, 2018 | Patent |